Symlin

Facts from the Community

From the BioVenturist base

Sales:

Amount Currency Year Area Company Reporting
  • 65,500,000
  • 2007
  • 11,500,000
  • 2005
  • 43,800,000
  • 2006
View entire collection »

Developed by:

Stage of development:

Indication or disease:

Disease Phase of development
View entire collection »

therapeutic molecule:

top ↑

We can tell you that Symlin is a…

If you know more about Symlin, you can add more facts here »

These people have edited this topic:

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!